mefloquine hydrochloride has been researched along with Plasmodium vivax Malaria in 1 studies
[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol : An organofluorine compound that consists of quinoline bearing trifluoromethyl substituents at positions 2 and 8 as well as a (2-piperidinyl)hydroxymethyl substituent at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lek-Uthai, U | 1 |
| Suwanarusk, R | 1 |
| Ruengweerayut, R | 1 |
| Skinner-Adams, TS | 1 |
| Nosten, F | 1 |
| Gardiner, DL | 1 |
| Boonma, P | 1 |
| Piera, KA | 1 |
| Andrews, KT | 1 |
| Machunter, B | 1 |
| McCarthy, JS | 1 |
| Anstey, NM | 1 |
| Price, RN | 1 |
| Russell, B | 1 |
1 other study available for mefloquine hydrochloride and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.
Topics: Animals; Antimalarials; Drug Resistance, Multiple; Gene Dosage; Genes, MDR; Genes, Protozoan; HIV In | 2008 |